NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Celeste Cagnazzo
A.O.U. Citta della Salute e della Scienza di Torino - Torino / Italy
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4978593
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Celeste Cagnazzo's MOST POPULAR ARTICLES
1-)
A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer M Aglietta, C Barone, MB Sawyer, MJ Moore, WH Miller Jr, C Bagalà, ... Annals of oncology 25 (9), 1750-1755, 2014 1992014
2-)
Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild‐type KRAS advanced biliary tract cancer: A randomized phase 2 … F Leone, D Marino, S Cereda, R Filippi, C Belli, R Spadi, G Nasti, ... Cancer 122 (4), 574-581, 2016 1242016
3-)
A multi-target lateral flow immunoassay enabling the specific and sensitive detection of total antibodies to SARS COV-2S Cavalera, B Colitti, S Rosati, G Ferrara, L Bertolotti, C Nogarol, ...Talanta 223, 121737, 2021842021
4-)
Fluoropyrimidine-induced cardiotoxicityI Depetris, D Marino, A Bonzano, C Cagnazzo, R Filippi, M Aglietta, ...Critical reviews in oncology/hematology 124, 1-10, 2018842018
5-)
Self-evaluation of adjuvant chemotherapy-related adverse effects by patients with breast cancerF Montemurro, G Mittica, C Cagnazzo, V Longo, P Berchialla, G Solinas, ...JAMA oncology 2 (4), 445-452, 2016772016
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept